Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors

    Receive Latest News

    Feedburner
    Share Us


    "FDA’s Part 11 ? Enforcement Trends and Affordable Steps to Take Today"

    View: 124

    Website https://compliance2go.com/product/?pid=CP2014-338 | Want to Edit it Edit Freely

    Category online

    Deadline: July 29, 2014 | Date: July 29, 2014-August 07, 2014

    Venue/Country: Houston, U.S.A

    Updated: 2014-06-17 15:10:14 (GMT+9)

    Call For Papers - CFP

    DESCRIPTION

    Why you should attend

    Since 2010, FDA has embarked on a special enforcement and training of its investigators on 21 CFR 11.

    Increasingly, Part 11 is an easy way for an investigator to cite a firm for failure to comply with the QSRs, GMPs, GLPs or GCPs. So if you don’t want to receive a Warning Letter from FDA citing you for data quality issues ? or you don’t want your submission to FDA to be put on hold due to data integrity questions ? then it’s time to understand how FDA views Part 11 today, how it enforces Part 11, and why compliance with 21 CFR 11 is an essential part of FDA compliance today.

    And yet, if you try to comply with Part 11 using outdated methodologies and “validate everything” interpretations, your costs will skyrocket and your risks will multiply.

    Part 11 compliance today requires a cost-effective, risk management mindset.

    For any assistance contact us at supportatcompliance2go.com or call us at 877.782.4696 Or Visit us:-https://compliance2go.com/product/?pid=CP2014-338


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.